CEACAM5 and neoplasm: Tumor markers reviewed prior to the fourth cycle revealed further elevation: CEA 1,953.75 ng/mL, CA125 23.4 U/mL, and CA19-9 3.70 U/mL (Figure 1, September 14, 2021).